Cas No.: | 145733-36-4 |
Chemical Name: | 2,4-dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one |
Synonyms: | WAY-ANA-756, Verdia, S1539_Selleck, ANA-756, AC1Q6LAA, Tasosartan (USAN/INN), DB01349, Tasosartan, AC1L1U5X |
SMILES: | O=C1N(CC2=CC=C(C3=CC=CC=C3C4=NN=NN4)C=C2)C(N=C5C)=C(C(C)=N5)CC1 |
Formula: | C23H21N7O |
M.Wt: | 411.45914 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Tasosartan is a long-acting angiotensin II (AngII) receptor blocker. Its long duration of action has been attributed to its active metabolite enoltasosartan. It is used to treat patients with essential hypertensionFor the detailed information of Tasosartan, the solubility of Tasosartan in water, the solubility of Tasosartan in DMSO, the solubility of Tasosartan in PBS buffer, the animal experiment (test) of Tasosartan, the cell expriment (test) of Tasosartan, the in vivo, in vitro and clinical trial test of Tasosartan, the EC50, IC50,and Affinity of Tasosartan, Please contact DC Chemicals. |